_id
690f3625ccc777a4e85d173d
Ticker
BKYI
Name
BIO-Key International Inc
Exchange
NASDAQ
Address
101 Crawfords Corner Road, Holmdel, NJ, United States, 07753
Country
USA
Sector
Industrials
Industry
Security & Protection Services
Currency
USD
Website
https://www.bio-key.com
Description
BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education sectors in the United States and internationally. It offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premise SaaS application, services, and cloud host, as well as windows device authentication through IAM platform. The company's solutions enable its customers to secure their workforces and student populations; and make their partner networks more collaborative. In addition, it provides BIO-key VST and WEB-key products; and civil and large-scale ID infrastructure solutions that develop finger-based biometric technology. Further, the company offers finger scanners for enterprise and consumer markets under SideSwipe, PIV Pro, EcoID II, and SidePass brand names; and fingerprint readers. Additionally, it provides identity and access management, user multi-factor authentication, and privilege entitlement and access control solutions. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 and is headquartered in Holmdel, New Jersey.
Last Close
0.691
Volume
279703
Current Price
0.695
Change
0.5788712011577429
Last Updated
2025-11-28T12:57:27.846Z
Image
-
Ipo Date
1997-02-14T00:00:00.000Z
Market Cap
8182379
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.9580285714285715
Sentiment Sources
7
Rating
4
Target Price
2
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
1549706
Cost Of Revenue
357988
Gross Profit
1191718
Operating Expenses
2083908
Operating Income
-892190
Interest Expense
13174
Pretax Income
-964849
Net Income
-964849
Eps
-0.14646588541326694
Dividends Per Share
-
Shares Outstanding
9955444
Income Tax Expense
-
EBITDA
-874080
Operating Margin
-57.571565187203255
Total Other Income Expense Net
-72659
Cash
2039853
Short Term Investments
-
Receivables
959503
Inventories
394176
Total Current Assets
3745907
Property Plant Equipment
136990
Total Assets
10113313
Payables
655647
Short Term Debt
434471
Long Term Debt
1000000
Total Liabilities
4068234
Equity
6045078
Depreciation
83991
Change In Working Capital
-388694
Cash From Operations
-1122764
Capital Expenditures
1326
Cash From Investing
-1325
Cash From Financing
962508
Net Change In Cash
-235491
PE
-
PB
0.757365931423879
ROE
-15.960902406883747
ROA
-9.540385035052312
FCF
-1124090
Fcf Percent
-0.7253569386709479
Piotroski FScore
0
Health Score
29
Deep Value Investing Score
4
Defensive Investing Score
6.5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.3
Garp Investing Score
2
Growth Investing Score
1
Momentum Investing Score
2.5
Net Net Investing Score
1
Quality Investing Score
2
Value Investing Score
4.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
1549706
Quarters > 0 > income Statement > cost Of Revenue
357988
Quarters > 0 > income Statement > gross Profit
1191718
Quarters > 0 > income Statement > operating Expenses
2083908
Quarters > 0 > income Statement > operating Income
-892190
Quarters > 0 > income Statement > interest Expense
13174
Quarters > 0 > income Statement > pretax Income
-964849
Quarters > 0 > income Statement > net Income
-964849
Quarters > 0 > income Statement > eps
-0.14646588541326694
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
6587534
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-874080
Quarters > 0 > income Statement > operating Margin
-57.571565187203255
Quarters > 0 > income Statement > total Other Income Expense Net
-72659
Quarters > 0 > balance Sheet > cash
2039853
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
959503
Quarters > 0 > balance Sheet > inventories
394176
Quarters > 0 > balance Sheet > total Current Assets
3745907
Quarters > 0 > balance Sheet > property Plant Equipment
136990
Quarters > 0 > balance Sheet > total Assets
10113313
Quarters > 0 > balance Sheet > payables
655647
Quarters > 0 > balance Sheet > short Term Debt
434471
Quarters > 0 > balance Sheet > long Term Debt
1000000
Quarters > 0 > balance Sheet > total Liabilities
4068234
Quarters > 0 > balance Sheet > equity
6045078
Quarters > 0 > cash Flow > net Income
-964849
Quarters > 0 > cash Flow > depreciation
83991
Quarters > 0 > cash Flow > change In Working Capital
-388694
Quarters > 0 > cash Flow > cash From Operations
-1122764
Quarters > 0 > cash Flow > capital Expenditures
1326
Quarters > 0 > cash Flow > cash From Investing
-1325
Quarters > 0 > cash Flow > cash From Financing
962508
Quarters > 0 > cash Flow > net Change In Cash
-235491
Quarters > 0 > ratios > PE
-0.14646588541326694
Quarters > 0 > ratios > PB
0.757365931423879
Quarters > 0 > ratios > ROE
-15.960902406883747
Quarters > 0 > ratios > ROA
-9.540385035052312
Quarters > 0 > ratios > FCF
-1124090
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-0.7253569386709479
Quarters > 0 > health Score
29
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
1696907
Quarters > 1 > income Statement > cost Of Revenue
464180
Quarters > 1 > income Statement > gross Profit
1232727
Quarters > 1 > income Statement > operating Expenses
2316577
Quarters > 1 > income Statement > operating Income
-1083850
Quarters > 1 > income Statement > interest Expense
85638
Quarters > 1 > income Statement > pretax Income
-1167396
Quarters > 1 > income Statement > net Income
-1167396
Quarters > 1 > income Statement > eps
-0.200544464453913
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
5821133
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-1041299
Quarters > 1 > income Statement > operating Margin
-63.8720919885415
Quarters > 1 > income Statement > total Other Income Expense Net
-83546
Quarters > 1 > balance Sheet > cash
2275344
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
1138303
Quarters > 1 > balance Sheet > inventories
318538
Quarters > 1 > balance Sheet > total Current Assets
4035230
Quarters > 1 > balance Sheet > property Plant Equipment
163328
Quarters > 1 > balance Sheet > total Assets
10516551
Quarters > 1 > balance Sheet > payables
889026
Quarters > 1 > balance Sheet > short Term Debt
598601
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
3664374
Quarters > 1 > balance Sheet > equity
6852177
Quarters > 1 > cash Flow > net Income
-1167396
Quarters > 1 > cash Flow > depreciation
100459
Quarters > 1 > cash Flow > change In Working Capital
17550
Quarters > 1 > cash Flow > cash From Operations
-880012
Quarters > 1 > cash Flow > capital Expenditures
1478
Quarters > 1 > cash Flow > cash From Investing
-1478
Quarters > 1 > cash Flow > cash From Financing
-35722
Quarters > 1 > cash Flow > net Change In Cash
-858408
Quarters > 1 > ratios > PE
-0.200544464453913
Quarters > 1 > ratios > PB
0.5904236617063453
Quarters > 1 > ratios > ROE
-17.036862883139182
Quarters > 1 > ratios > ROA
-11.100559489513245
Quarters > 1 > ratios > FCF
-881490
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-0.5194686567973378
Quarters > 1 > health Score
30
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
1607159
Quarters > 2 > income Statement > cost Of Revenue
279498
Quarters > 2 > income Statement > gross Profit
1327661
Quarters > 2 > income Statement > operating Expenses
1968299
Quarters > 2 > income Statement > operating Income
-640638
Quarters > 2 > income Statement > interest Expense
95910
Quarters > 2 > income Statement > pretax Income
-736545
Quarters > 2 > income Statement > net Income
-736545
Quarters > 2 > income Statement > eps
-0.1566310204892331
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
4702421
Quarters > 2 > income Statement > income Tax Expense
-22998
Quarters > 2 > income Statement > EBITDA
-542608
Quarters > 2 > income Statement > operating Margin
-39.861519613180775
Quarters > 2 > income Statement > total Other Income Expense Net
-95907
Quarters > 2 > balance Sheet > cash
3133752
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
843727
Quarters > 2 > balance Sheet > inventories
357842
Quarters > 2 > balance Sheet > total Current Assets
4589606
Quarters > 2 > balance Sheet > property Plant Equipment
190128
Quarters > 2 > balance Sheet > total Assets
11183676
Quarters > 2 > balance Sheet > payables
568836
Quarters > 2 > balance Sheet > short Term Debt
926078
Quarters > 2 > balance Sheet > long Term Debt
11666
Quarters > 2 > balance Sheet > total Liabilities
3656623
Quarters > 2 > balance Sheet > equity
7527053
Quarters > 2 > cash Flow > net Income
-736545
Quarters > 2 > cash Flow > depreciation
98027
Quarters > 2 > cash Flow > change In Working Capital
-421232
Quarters > 2 > cash Flow > cash From Operations
-835312
Quarters > 2 > cash Flow > capital Expenditures
4570
Quarters > 2 > cash Flow > cash From Investing
-4570
Quarters > 2 > cash Flow > cash From Financing
3529227
Quarters > 2 > cash Flow > net Change In Cash
2696148
Quarters > 2 > ratios > PE
-0.1566310204892331
Quarters > 2 > ratios > PB
0.4341915215689327
Quarters > 2 > ratios > ROE
-9.785303756994935
Quarters > 2 > ratios > ROA
-6.585893582754007
Quarters > 2 > ratios > FCF
-839882
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-0.522587995338358
Quarters > 2 > health Score
33
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
1462278
Quarters > 3 > income Statement > cost Of Revenue
262360
Quarters > 3 > income Statement > gross Profit
1199918
Quarters > 3 > income Statement > operating Expenses
2729894
Quarters > 3 > income Statement > operating Income
-1267616
Quarters > 3 > income Statement > interest Expense
66932
Quarters > 3 > income Statement > pretax Income
-1407495
Quarters > 3 > income Statement > net Income
-1384497
Quarters > 3 > income Statement > eps
-0.3726290767579881
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
3715483
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-86.68775704756551
Quarters > 3 > income Statement > total Other Income Expense Net
-
Quarters > 3 > balance Sheet > cash
437604
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
718229
Quarters > 3 > balance Sheet > inventories
378307
Quarters > 3 > balance Sheet > total Current Assets
1886958
Quarters > 3 > balance Sheet > property Plant Equipment
213570
Quarters > 3 > balance Sheet > total Assets
8615560
Quarters > 3 > balance Sheet > payables
818187
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
44762
Quarters > 3 > balance Sheet > total Liabilities
4843529
Quarters > 3 > balance Sheet > equity
3772031
Quarters > 3 > cash Flow > net Income
-1567190
Quarters > 3 > cash Flow > depreciation
175146
Quarters > 3 > cash Flow > change In Working Capital
689323
Quarters > 3 > cash Flow > cash From Operations
-514564
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-833560
Quarters > 3 > cash Flow > net Change In Cash
-1363533
Quarters > 3 > ratios > PE
-0.3726290767579881
Quarters > 3 > ratios > PB
0.6845809817045512
Quarters > 3 > ratios > ROE
-36.70428477390562
Quarters > 3 > ratios > ROA
-16.06972733055077
Quarters > 3 > ratios > FCF
-514564
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-0.35189204788692713
Quarters > 3 > health Score
24
Valuation > metrics > PE
-0.14646588541326694
Valuation > metrics > PB
0.757365931423879
Valuation > final Score
70
Valuation > verdict
24.3% Undervalued
Profitability > metrics > ROE
-15.960902406883747
Profitability > metrics > ROA
-25.75742003205098
Profitability > metrics > Net Margin
-0.6226013192179678
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.6729828796253745
Risk > metrics > Interest Coverage
-67.72354637923182
Risk > final Score
-223
Risk > verdict
High
Liquidity > metrics > Current Ratio
3.4362399299892306
Liquidity > metrics > Quick Ratio
3.074649716819647
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-3
Prev Risks > 1
33
Prev Risks > 2
-46
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T00:17:02.728Z
BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education sectors in the United States and internationally. It offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premise SaaS application, services, and cloud host, as well as windows device authentication through IAM platform. The company's solutions enable its customers to secure their workforces and student populations; and make their partner networks more collaborative. In addition, it provides BIO-key VST and WEB-key products; and civil and large-scale ID infrastructure solutions that develop finger-based biometric technology. Further, the company offers finger scanners for enterprise and consumer markets under SideSwipe, PIV Pro, EcoID II, and SidePass brand names; and fingerprint readers. Additionally, it provides identity and access management, user multi-factor authentication, and privilege entitlement and access control solutions. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 and is headquartered in Holmdel, New Jersey.
Stock Price
$ 0.00
0% increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ABIO-key International Inc. (BKYI) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
12/13/2025
BIO-key International Inc. (BKYI) Stock Price | Live Quotes & Charts | NASDAQ StocksToTrade
Read more →BIO-key International (NASDAQ:BKYI) versus Viscount Systems (OTCMKTS:VSYS) Critical Analysis Defense World
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$2
Analyst Picks
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Medium
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 1.24% of the total shares of BIO-Key International Inc
1.
TWO SIGMA SECURITIES, LLC(0.4252%)
since
2025/06/30
2.
Geode Capital Management, LLC(0.385%)
since
2025/06/30
3.
UBS Group AG(0.2062%)
since
2025/06/30
4.
GSA Capital Partners LLP(0.194%)
since
2025/06/30
5.
Tower Research Capital LLC(0.0262%)
since
2025/06/30
6.
SBI Securities Co Ltd(0.0044%)
since
2025/06/30
7.
Bank of America Corp(0.0007%)
since
2025/06/30
8.
HARBOUR INVESTMENTS, INC.(0.0001%)
since
2025/06/30
9.
Goss Wealth Management LLC(0.0001%)
since
2025/06/30
10.
Wells Fargo & Co(0%)
since
2025/06/30
11.
Citigroup Inc(0%)
since
2025/06/30
12.
Citadel Advisors Llc(0%)
since
2025/03/31
13.
JPMorgan Chase & Co(0%)
since
2025/06/30
14.
Armistice Capital, LLC(0%)
since
2025/06/30
15.
Virtu Financial LLC(0%)
since
2025/06/30
16.
Advisor Group Holdings, Inc.(0%)
since
2025/06/30
17.
XTX Topco Ltd(0%)
since
2025/03/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.